PEA and Vitamin B Composition for Neuropathic Pain Relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for neuropathic pain, such as those involving anti-depressants, gabapentinoids, and opioids, often result in suboptimal pain relief and are limited by significant side effects, making it difficult to achieve effective doses without adverse reactions.
Innovation Solution
A composition comprising palmitoylethanolamide (PEA) and one or more vitamins of the vitamin B complex, used as the sole pharmaceutically active ingredients, which enhances analgesic efficacy while minimizing side effects and allowing for faster onset of action.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current therapeutic compositions (anti-depressants, gabapentinoids, opioids) are used to treat neuropathic pain, then pain relief is achieved to some extent, but side effects and safety issues become significant and dose-limiting
Solution Approach 1:
The patent extracts and eliminates the harmful side effects associated with conventional neuropathic pain medications by using a completely different mechanism of action. Instead of using anti-depressants, gabapentinoids, or opioids that cause cardiac disturbances, drowsiness, dizziness, constipation, nausea, and abuse potential, the invention uses palmitoylethanolamide (PEA) combined with vitamin B complex - natural compounds that achieve pain relief without these harmful effects.
Solution Approach 2:
The patent changes the chemical and pharmacological parameters of the treatment by substituting conventional pharmaceutical compounds with a combination of PEA and vitamin B complex. This parameter change includes using compounds with different mechanisms of action (endocannabinoid system modulation and neurotrophic support) that inherently lack the dose-limiting side effects of traditional medications while maintaining analgesic efficacy.
2Reliability
If higher doses of current pain-relieving drugs are administered to overcome partial efficacy, then pain reduction may improve, but side effects become more severe and treatment becomes intolerable
Solution Approach 1:
The patent converts the previously harmful approach of increasing doses to overcome partial efficacy into a beneficial approach by using a different compound combination that achieves effective pain relief at tolerable doses. The PEA-vitamin B complex combination provides sufficient analgesic effect without requiring dose escalation, thereby eliminating the trade-off between efficacy and tolerability that plagues conventional treatments.
3Reliability
If combinations of multiple analgesic compounds are prescribed to improve efficacy, then pain relief may be enhanced, but the number of side effects and safety concerns increase
Solution Approach 1:
The patent merges two beneficial compounds - palmitoylethanolamide (PEA) and vitamin B complex - into a single therapeutic regimen that works synergistically to relieve neuropathic pain. This combination approach achieves enhanced efficacy through complementary mechanisms of action (PEA modulating the endocannabinoid system and vitamin B providing neurotrophic support) while avoiding the complexity and cumulative side effects of combining multiple conventional analgesics from different classes.
Data Source
Figure 1
AI summary
The present invention relates to a composition comprising palmitoylethanolamide (PEA) and a vitamin B. The present invention also relates to such a composition for use as a nutraceutical or as a medicament, for use as an analgesic pharmaceutical, and more specifically for use as an analgesic pharmaceutical in the alleviation of neuropathic pain, and to a method for preparing such a composition.